ISSN: 1538-4721

Journal Home

Journal Guideline

Brachytherapy Q2 Unclaimed

Elsevier Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Brachytherapy is a journal indexed in SJR in Oncology and Radiology, Nuclear Medicine and Imaging with an H index of 57. It has a price of 2970 €. It has an SJR impact factor of 0,593 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,593.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Radiology, Nuclear Medicine and Imaging (Q2) Oncology (Q3)

Price

2970 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,593

SJR Impact factor

57

H Index

111

Total Docs (Last Year)

385

Total Docs (3 years)

3648

Total Refs

676

Total Cites (3 years)

365

Citable Docs (3 years)

1.59

Cites/Doc (2 years)

32.86

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

International Journal of Oncology Q2
BMC Cancer Q2
Cancer Epidemiology Q2
Frontiers in Oncology Q2
Journal of Geriatric Oncology Q2

Compare this journals

Aims and Scope

Best articles by citations

Pulsed-dose rate brachytherapy with concomitant chemotherapy and interstitial hyperthermia in patients with recurrent head-and-neck cancer

Clinical outcomes from an innovative protocol using serial ultrasound imaging and a single MR image to guide brachytherapy for locally advanced cervix cancer

Inconsistency, perspective, double talk, and false virtue

Inverse-planned gynecologic high-dose-rate interstitial brachytherapy: Clinical outcomes and dose-volume histogram analysis

The use of mutual information in registration of CT and MRI datasets post permanent implant

Definition of vaginal doses in intrauterine high-dose-rate brachytherapy

The MammoSite‚Ñ¢ breast brachytherapy applicator: A review of technique and outcomes

Prostate brachytherapy in obese patients

Prostate brachytherapy under local anesthesia

Can intensity-modulated radiation therapy replace brachytherapy in the management of cervical cancer?

Late urinary function after prostate brachytherapy

Palliative treatment by high-dose-rate intraluminal brachytherapy in patients with advanced esophageal cancer

SHOW MORE ARTICLES

Combined intensity-modulated radiation therapy vs. three-dimensional highly conformal radiotherapy after 125I prostate permanent seed brachytherapy: A comparative treatment planning study

The sculpted pear: An unfinished brachytherapy tale

LDR vs. HDR brachytherapy for localized prostate cancer

Efficacy and safety of iodine-125 radioactive seeds brachytherapy for advanced non-small cell lung cancer - A meta-analysis

Identification of pubic arch interference in prostate brachytherapy:

The role of seed implantation in patients with unresectable pancreatic carcinoma after relief of obstructive jaundice using ERCP

Permanent prostate brachytherapy with or without supplemental external beam radiotherapy as practiced in Japan: Outcomes of 1300 patients

Brachytherapy for pediatric tumors

Factors predicting an increased dose to the penile bulb in permanent seed prostate brachytherapy

Brachytherapy improves outcomes in young men (=60 years) with prostate cancer: A SEER analysis

A Monte Carlo evaluation of the dosimetric characteristics of the EchoSeed‚Ñ¢ Model 6733 125I brachytherapy source

Radical radiotherapy compared with surgery for advanced squamous cell carcinoma of the base of tongue